Optimizing Your Study Data Submissions

Optimizing Your Study Data Submissions Information Guide

1. Introduction of Optimizing Your Study Data Submissions
2. Core Information
3. Recent Updates
4. Deep Dive
5. Future Outlook

Introduction of Optimizing Your Study Data Submissions

FDA provides an overview of recent updates made to FDA's CBER held a discussion on CBER's support and requirement starting March 15, 2023, for Advice from an Indiana Law Journal Executive Articles Editor on CBER's Bhanu Kannan provides a perspective from CBER's Office of Compliance and Biologics Quality Bioresearch Monitoring ... CBER's Brenda Baldwin and Kirk Prutzman discuss timing of This is part 2 of GREI's three-part series showcasing tools and examples that make it easier to plan, share, and

Webinar presenters Ron Fitzmartin, Brenda Baldwin, Kirk Prutzman, and Bhanu Kannan respond to audience questions.

Core Information

Recent Updates

Optimizing Law Review Submissions (Advice From An Executive Articles Editor)

Updates to the Study Data Technical Conformance Guide (1of4) Technical Conformance– Jul. 13, 2017

Biologics Quality Bioresearch and Study Data Submissions (3of4) Technical Conformance– Jul. 13, 2017

Study Data Submissions: Office of Vaccines Research and Review (OVRR) Data Submission – May 8, 2018

How to Get the Most Out of Studying: Part 4 of 5, "Putting Principles for Learning into Practice"

Providing Clinical Study Data to the Office of Vaccines (2of4) Tech Conformance – Jul. 13, 2017

Improving Data Sharing with GREI’s Submission Checklist

FDA guide for submitting SAS programs | optimize your programming set-up from the beginning

Panel Questions and Discussion (4of4) Study Data Technical Conformance Webinar – Jul. 13, 2017

Deep Dive

Data is compiled from public records and verified media reports.

Last Updated: June 16, 2026

Future Outlook

Disclaimer: Disclaimer: Details estimates are based on publicly available data, media reports, and financial analysis. Actual numbers may vary.